10584-64-2 (肟并[c]菲并[1,2-d]吡喃-3,5,8(3aH,4bH,6H)-酮,1-(3-呋喃基)十氢-4b,7,7,10a,12a-五甲基-(1S,3aS,4aR,4bR,6aR,10aS,10bR,12aS)-,Oxireno[c]phenanthro[1,2-d]pyran-3,5,8(3aH,4bH,6H)-one,1-(3-furanyl)decahydro-4b,7,7,10a,12a-pentamethyl-,(1S,3aS,4aR,4bR,6aR,10aS,10bR,12aS)-)

CAS号:
10584-64-2
中文名称:
肟并[c]菲并[1,2-d]吡喃-3,5,8(3aH,4bH,6H)-酮,1-(3-呋喃基)十氢-4b,7,7,10a,12a-五甲基-(1S,3aS,4aR,4bR,6aR,10aS,10bR,12aS)-
英文名称:
Oxireno[c]phenanthro[1,2-d]pyran-3,5,8(3aH,4bH,6H)-one,1-(3-furanyl)decahydro-4b,7,7,10a,12a-pentamethyl-,(1S,3aS,4aR,4bR,6aR,10aS,10bR,12aS)-
分子式:
C26H32O6
分子量:
440.528688430786

肟并[c]菲并[1,2-d]吡喃-3,5,8(3aH,4bH,6H)-酮,1-(3-呋喃基)十氢-4b,7,7,10a,12a-五甲基-(1S,3aS,4aR,4bR,6aR,10aS,10bR,12aS)-(10584-64-2)名称与标识符

名称

英文别名:
Oxireno[c]phenanthro[1,2-d]pyran-3,5,8(3aH,4bH,6H)-one,1-(3-furanyl)decahydro-4b,7,7,10a,12a-pentamethyl-,(1S,3aS,4aR,4bR,6aR,10aS,10bR,12aS)-;1,2-Dihydro-7-oxo-7-deacetyl-gedunin;Ekeberin C1;Oxireno[c]phenanthro[1,2-d]pyran-3,5,8(3aH,4bH,6H)-one,1-(3-furanyl)decahydro-4b,7,7,10a,12a-pentamethyl-,(1S,3aS,4aR,4bR,6aR;1,2-dihydro-6-nitro-2-oxo-3-quinolinecarboxylic acid;2-hydroxy-6-nitroquinoline-3-carboxylic acid;2-Hydroxy-6-nitro-quinoline-3-carboxylicacid;ANW-61359;CTK5F5874;SBB066343;7-Oxodihydrogedunin;(13α,17S)-14β,15β:16,17-Diepoxy-16,17-secomeliacane-3,7,16-trione;(13α,17aα)-4,4,8-Trimethyl-14β,15β:21,23-diepoxy-D-homo-24-nor-17-oxa-5α-chola-20,22-diene-3,7,16-trione;(13α,17aα)-14β,15β:21,23-Diepoxy-4,4,8-trimethyl-D-homo-24-nor-17-oxa-5α-chola-20,22-diene-3,7,16-trione;(13α,17aα)-14β,15β:21,23-Diepoxy-4,4,8-trimethyl-17-oxa-D-homo-24-nor-5α-chola-20,22-diene-3,7,16-trione;16,13.alpha.,14.beta.,17.alpha.-chola-20,22-dien-16-oic acid, 14,15.beta.:21,23-diepoxy-17-hydroxy-4,4,8-trimethyl-3,7-dioxo-, .delta.-lactone;Oxireno[c]phenanthro[1,2-d]pyran-3,5,8(3aH,4bH,6H)-one, 1-(3-furanyl)decahydro-4b,7,7,10a,12a-pentamethyl-, (1S,3aS,4aR,4bR,6aR,10aS,10bR,12aS)-;10584-64-2;7-(furan-3-yl)-1,8,12,16,16-pentamethyl-3,6-dioxapentacyclo[9.8.0.02,4.02,8.012,17]nonadecane-5,15,19-trione;KETODIHYDROGENDUNIN;1-(3-Furyl)-4b,7,7,10a,12a-pentamethyldecahydronaphtho[2,1-f]oxireno[2,3-d]isochromene-3,5,8(3ah,4bh,6H)-trione #;D-Homo-24-nor-17-oxachola-20,22-diene-3,7,16-trione, 14,15:21,23-diepoxy-4,4,8-trimethyl-, (5.alpha.,13.alpha.,14.beta.,15.beta.,17a.alpha.)-;NSC309911;DTXSID70316988;HUKMOJLAHVSCJE-UHFFFAOYSA-N;16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-20,22-dien-16-oic acid, 14,15.beta.:21,23-diepoxy-17-hydroxy-4,4,8-trimethyl-3,7-dioxo-, .delta.-lactone;D-Homo-24-nor-17-oxachola-20,7,16-trione, 14,15:21,23-diepoxy-4,4,8-trimethyl-, (5.alpha.,13.alpha.,14.beta.,15.beta.,17a.alpha.)-;NSC-309911;CHEMBL484837;7-ketodihydrogedunin;(-)-Ekeberin C1;

标识符

InChIKey:
HUKMOJLAHVSCJE-UHFFFAOYSA-N
Inchi:
1S/C26H32O6/c1-22(2)16-12-18(28)25(5)15(23(16,3)9-7-17(22)27)6-10-24(4)19(14-8-11-30-13-14)31-21(29)20-26(24,25)32-20/h8,11,13,15-16,19-20H,6-7,9-10,12H2,1-5H3
SMILES:
O1C2C(=O)OC(C3=COC=C3)C3(C)CCC4C5(C)CCC(C(C)(C)C5CC(C4(C)C132)=O)=O

肟并[c]菲并[1,2-d]吡喃-3,5,8(3aH,4bH,6H)-酮,1-(3-呋喃基)十氢-4b,7,7,10a,12a-五甲基-(1S,3aS,4aR,4bR,6aR,10aS,10bR,12aS)-(10584-64-2)物化性质

实验特性

  • LogP : 4.42210
  • PSA : 86.11

计算特性

  • 精确分子量 : 440.21996
  • 氢键供体数量 : 0
  • 氢键受体数量 : 6
  • 可旋转化学键数量 : 1
  • 同位素质量 : 440.21988874g/mol
  • 重原子数量 : 32
  • 复杂度 : 925
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 0
  • 不确定原子立构中心数量 : 8
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 3.1
  • 拓扑分子极性表面积 : 86.1Ų